Evidence map›Paper›PMID 10942204›Full record

ArticleMolecular and cellular biochemistry2000

Toxoplasma gondii induces the secretion of monocyte chemotactic protein-1 in human fibroblasts, in vitro.

M P Brenier-Pinchart, H Pelloux, J Simon, J Ricard, J L Bosson, P Ambroise-Thomas

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Inhibitory Effects ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  2. Article
  3. Review
  4. Article
  5. Recurrent headaches may be caused by cerebral toxoplasmosis.World journal of clinical pediatrics · 2014
    Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M P Brenier-PinchartDépartement de Parasitologie-Mycologie Médicale et Moléculaire (RHAP- DP3M) UPRES-A CNRS 5082, Faculté de Médecine, Université Joseph Fourier, Grenoble 1, La Tronche, France.
H Pelloux
J Simon
J Ricard
J L Bosson
P Ambroise-Thomas
Centre National de la Recherche Scientifique · FRUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secretion of Monocyte Chemotactic Protein-1 (MCP-1) by fibroblasts infected with Toxoplasma gondii was studied in vitro. A significantly higher MCP-1 secretion was observed 24 h after infection by live tachyzoites. Analysis of chemokine mRNA transcripts by RNase protection assay revealed that this MCP-1 secretion seems associated with increased MCP-1 mRNA expression. However, these increased levels of MCP-1 secretion and expression were not obtained after stimulation by heat-killed tachyzoites or parasites pre-treated by a specific inhibitor of phosphatidylcholine-specific phospholipase C (D609). Inhibition of parasite multiplication by pyrimethamine did not modify MCP-1 secretion. Thus, it appeared that the active penetration of T. gondii in cells was of major importance in the induction of MCP-1 secretion. None of the other chemokines studied by RNase protection assay (lymphotactin, RANTES, IP-10, MIP-1alpha, MIP-1beta, IL-8, and I-309) were expressed after infection by live tachyzoites. We also found that MCP-1 secretion induced by live T. gondii is blocked by inhibitors of nuclear factor (NF)-kappaB activation, ALLN and MG132. Such data indicate that NF-kappaB could be involved in T. gondii-induced MCP-1 production. MCP-1 secretion may contribute to the recruitment of monocytes and lymphocytes and thus participate in the control of T. gondii infection and in its pathogenesis.

Indexed as

AnimalsAntiprotozoal AgentsBridged-Ring CompoundsCells, CulturedChemokine CCL2ChemokinesEnzyme InhibitorsFibroblastsGene Expression RegulationHumansKineticsLeupeptinsMiceNorbornanesProlinePyrimethamineAntiprotozoal Agentsbenzyloxycarbonylleucyl-leucyl-leucine aldehydeBridged-Ring CompoundsChemokine CCL2ChemokinesEnzyme InhibitorsLeupeptinsNorbornanesProlineprolinedithiocarbamatePyrimethamineThiocarbamatesThionestricyclodecane-9-yl-xanthogenateType C Phospholipases

Identifiers

PMID10942204
OpenAlexW1575796956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.